| ABCB1 | ABC transporters multidrug resistance 1 |
| ABCG2 | ABC transporters |
| ADMET | Chemical absorption, distribution, metabolism, excretion, and toxicity |
| ADT | Androgen deprivation therapy |
| Ag | Agonist |
| Akt | Serine/threonine kinase |
| ALK | Anaplastic lymphoma kinase |
| AMPK/mTOR | AMP-activated protein kinase/mechanistic target of rapamycin kinase |
| APC | Adenomatous polyposis coli gen |
| AR | Androgen receptor |
| AZA | Acetazolamide |
| BAX | BCL2 associated X protein |
| BBB | Blood–brain barrier |
| Bcl-XL | B-cell lymphoma-extra large |
| BTB | Blood–tumor barrier |
| BCL-2 | B-cell lymphoma 2 |
| BTCP | 2-bicyclo[2.2.1]hept-5-enyl-1H-1,3,7,8-tetraazacyclopenta[l]phenanthrene |
| CA | Carbonic anhydrase |
| cAMP | Cyclic adenosine monophosphate |
| CDK2 | Cyclin dependent kinase 2 |
| c-Met | Mesenchymal epithelial transition factor |
| DA | Diels–Alder |
| DDS | Drug delivery systems |
| DNA | Deoxyribonucleic acid |
| EC50 | Half maximal effective concentration |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial mesenchymal transmission |
| ER | Estrogen receptors |
| ERK | Estrogen receptor kinase |
| FAM46C | Non-canonical poly(A) polymerase protein |
| FDA | Food drug administration |
| HDAC | Histone deacetylase |
| HUVEC | Human Umbilical Vein Endothelial Cell |
| IARC | International Agency for Research on Cancer |
| IC50 | Half maximal inhibitory concentration |
| InR | Insulin receptor |
| JNK | c-Jun N-terminal kinase |
| Ki | Inhibitory constant |
| LC3-IIB | Microtubule-associated protein 1A/1B-light chain 3-phosphatidylethanolamine conjugate B |
| MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 |
| MAP | Mitogen-activated protein |
| MCL-1 | Myeloid cell leukemia-1 |
| MEK1/2 | Mitogen-activated protein kinase kinases 1/2 |
| MOF | Metal–organic framework |
| MT | Mutant type |
| PDAC | Pancreatic ductal adenocarcinoma |
| P-gp | MDR1/P-glycoprotein |
| Ras | Rat sarcoma virus |
| RNS | Reactive nitrogen species |
| ROS | Reactive oxygen species |
| SAR | Structure–activity relationship |
| SDHB | Succinate dehydrogenase complex subunit b |
| SI | Selectivity Index |
| SIRT7 | Sirtuin protein 7 |
| SQSTM1/p62 | Sequestosome 1 |
| TGI | Total growth inhibition |
| TNF | Tumor necrosis factor |
| TRPM8 | Transient receptor potential cation channel subfamily M member 8 |
| VEGFR-2 | Vascular endothelial growth factor receptor 2 |
| WT | Wild type |